About Bourgoin Insights Group
Built to turn strategy into execution.
Bourgoin Insights Group was founded to address a common gap: strong ideas that never make it into practice.
BIG exists to help organizations define strategy and build the systems that support it — with a focus on efficiency, clarity, and real execution. We believe that progress happens when thinking and doing are tightly connected.
Our work is shaped by a simple principle: systems should make work easier, not more complicated.
How BIG Works
BIG operates with a lean, focused model designed to move quickly without sacrificing quality.
We combine:
strategic thinking
system design
practical execution
thoughtful use of modern technology and intelligent tools
This approach allows small teams to accomplish work that would traditionally require much larger organizations.
Andrew Bourgoin
PRINCIPAL, Bourgoin Insights Group, LLC
Andrew Bourgoin has over 15 years of experience working in complex, highly regulated environments, including the U.S. pharmaceutical and biosimilars markets. His background spans strategy, analytics, market intelligence, and execution across multiple industry-leading organizations.
Andrew founded Bourgoin Insights Group to build solutions — not just provide advice. Through BIG and platforms like All Things Biosimilar, he focuses on creating systems that help organizations make better decisions and move forward with confidence.
Based in Maine, Andrew leads BIG with a founder-led, hands-on approach, partnering closely with clients to design and deliver work that actually gets used.
About All Things Biosimilar
All Things Biosimilar is a flagship platform built by BIG and serves as a real-world example of the firm’s approach in action. It demonstrates how clear strategy, focused execution, and efficient systems can create durable value in complex markets.
